Leuthold Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Leuthold Group, LLC

$885 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $131,605 - $156,105	-188 Reduced 3.52%	5,157 $3.71 Million
Q1 2023 Apr 18, 2023	SELL	$680.49 - $826.97 $74,853 - $90,966	-110 Reduced 2.02%	5,345 $4.39 Million
Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $88,942 - $96,565	-126 Reduced 2.26%	5,455 $3.94 Million
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $64,858 - $81,848	-113 Reduced 1.98%	5,581 $3.85 Million
Q2 2022 Aug 01, 2022	BUY	$548.35 - $738.84 $3.12 Million - $4.21 Million	5,694 New	5,694 $3.37 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $5.15 Million - $6.08 Million	-10,892 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $461,918 - $566,838	-1,034 Reduced 8.67%	10,892 $5.15 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $369,725 - $469,968	-773 Reduced 6.09%	11,926 $5.76 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $136,732 - $165,210	-251 Reduced 1.94%	12,699 $7.11 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $160,329 - $209,274	-325 Reduced 2.45%	12,950 $8.08 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $394,675 - $580,460	-1,174 Reduced 8.13%	13,275 $6.48 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $3.96 Million - $5.44 Million	14,449 New	14,449 $5.43 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $3.36 Million - $3.91 Million	-12,281 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $207,323 - $287,055	-692 Reduced 5.33%	12,281 $3.84 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.71 Million - $2.02 Million	4,589 Added 54.74%	12,973 $5.33 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $211,902 - $254,318	-631 Reduced 7.0%	8,384 $3.13 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $3.17 Million - $3.68 Million	9,015 New	9,015 $3.64 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.

Account